Terapia de reemplazo hormonal y riesgo de infarto del miocardio

Autores/as

  • Donald Fernández Morales Caja Costarricense del Seguro Social, Hospital México

DOI:

https://doi.org/10.51481/amc.v49i2.311

Resumen

Los componentes de la enfermedad cardiovascular son la coronariopatía y el accidente cerebrovascular. Entre sus factores de riesgo se mencionan: el aumento de la tensión arterial, el incremento en el colesterol, el fumado, la inactividad física, la mala nutrición, el sobrepeso y la Diabetes Mellitus

Citas

De Vries, C.S. Bromley, S. Farmer, R. Myocardial infarction and hormone replacement: Differences between products. Maturitas 2006; 53: 343 – 350

The writing group for the PEPI trial. Effects of estrogen or estrogen / Progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199 – 208

Newton, K. LaCroix, A. McKnight, B. Knopp, R. Siscovick, D. Heckbert, S. Weiss, N. Estrogen replacement therapy and prognosis after fist myocardial infarction. Am J Epidemiol 1997; 145: 269 – 277

Hulley, S. Grady, D. Bush, T. Furbert, C. Herrington, D. Riggs, B. Vittinghoff, E. Randomized trial of estrogen plus progestin for secundary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605–613

The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy. The women’s health initiative randomized controlled trial. JAMA 2004;291: 1701–1712

Grady, D. Herrington, D. Bittner, V. Blumenthal, R. Davidson, M. Hlatky, M. Et al. Cardiovascular outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 49 - 57

Lobo, R. Views on recent trials and the future of hormonal therapy. Clin Obstet Gynecol 2004; 47:424-427

Prentice, R. Langer, R. Stefanick, M. Howard, B. Pettinger, M. Anderson, G. et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women’s health initiative Clinical Trial. Am J Epidemiol 2005; 162: 404 – 414

Ouyang, P. Michos, E. Karas, R. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 2006; 47: 1741 - 1753

Descargas

Publicado

2007-04-01

Cómo citar

Fernández Morales, D. (2007). Terapia de reemplazo hormonal y riesgo de infarto del miocardio. Acta Médica Costarricense , 49(2), 124-125. https://doi.org/10.51481/amc.v49i2.311